Ask our Experts
Dr. Paul Quigley is a Principal Research Fellow of Drug Substance at Quotient Sciences. Paul has over 20 years of experience in the fine chemical and pharmaceutical industries in a variety of senior management roles, covering technical management of UK sites, and senior project and operational roles within a number of international organizations, including ICI, Schering Plough, Clariant, Johnson Matthey, and Rhodia.
Paul has co-authored a number of papers and generated several patents in areas including biocatalysis, organic synthesis, and polymer chemistry. He is a member of the Royal Society of Chemistry and the Association of MBAs. He holds a PhD in Natural Product Chemistry from University College Dublin and an MBA from Warwick Business School.
In this article, Paul shares some of his experience with drug substance and drug product development. He discusses the benefits of the fully integrated drug substance, drug product, and clinical testing capabilities at Quotient Sciences.